These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 20498136

  • 1. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T, Mathis A, Erb G, Namer IJ, Hode Y, Demazières A, Luthringer R.
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [Abstract] [Full Text] [Related]

  • 2. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety.
    Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demaziere A, Luthringer R, Macher JP.
    Neuroimage; 2006 Jul 01; 31(3):1197-208. PubMed ID: 16600640
    [Abstract] [Full Text] [Related]

  • 3. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A.
    J Psychopharmacol; 2009 Jun 01; 23(4):460-4. PubMed ID: 18562429
    [Abstract] [Full Text] [Related]

  • 4. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G, Mulert C, Eser D, Sämann PG, Ertl M, Laenger A, Karch S, Pogarell O, Meindl T, Czisch M, Rupprecht R.
    Biol Psychiatry; 2013 Feb 15; 73(4):337-44. PubMed ID: 23059050
    [Abstract] [Full Text] [Related]

  • 5. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, Sedman A.
    Biol Psychiatry; 1995 Dec 01; 38(11):742-6. PubMed ID: 8580227
    [Abstract] [Full Text] [Related]

  • 6. Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.
    Schunck T, Mathis A, Erb G, Namer IJ, Demazières A, Luthringer R.
    J Psychopharmacol; 2010 May 01; 24(5):701-8. PubMed ID: 19460871
    [Abstract] [Full Text] [Related]

  • 7. Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers.
    Eser D, Leicht G, Lutz J, Wenninger S, Kirsch V, Schüle C, Karch S, Baghai T, Pogarell O, Born C, Rupprecht R, Mulert C.
    Hum Brain Mapp; 2009 Feb 01; 30(2):511-22. PubMed ID: 18095276
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.
    Paulus MP, Feinstein JS, Castillo G, Simmons AN, Stein MB.
    Arch Gen Psychiatry; 2005 Mar 01; 62(3):282-8. PubMed ID: 15753241
    [Abstract] [Full Text] [Related]

  • 9. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J.
    Depress Anxiety; 1998 Mar 01; 8(1):1-7. PubMed ID: 9750972
    [Abstract] [Full Text] [Related]

  • 10. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.
    Psychiatry Res; 2010 Jul 30; 178(2):342-7. PubMed ID: 20471107
    [Abstract] [Full Text] [Related]

  • 11. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E, Tõru I, Tasa G, Must A, Toover E, Lang A, Vasar V, Shlik J.
    Neurosci Lett; 2008 Dec 03; 446(2-3):88-92. PubMed ID: 18832011
    [Abstract] [Full Text] [Related]

  • 12. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects.
    Ströhle A, Graetz B, Scheel M, Wittmann A, Feller C, Heinz A, Dimeo F.
    J Psychiatr Res; 2009 Aug 03; 43(12):1013-7. PubMed ID: 19289240
    [Abstract] [Full Text] [Related]

  • 13. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 03; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 14. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov 03; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 15. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Nov 03; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]

  • 16. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan 03; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 17. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E, Tõru I, Vasar V, Shlik J.
    J Psychopharmacol; 2004 Jun 03; 18(2):194-9. PubMed ID: 15260907
    [Abstract] [Full Text] [Related]

  • 18. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D, Cox BJ, Bradwejn J.
    Am J Psychiatry; 1993 Dec 03; 150(12):1881-3. PubMed ID: 8238648
    [Abstract] [Full Text] [Related]

  • 19. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar 03; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 20. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr 03; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.